A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 11, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CHAR SEC filings page.
This page shows Charlton Aria Acquisition Corporation (CHAR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
This acquisition vehicle reports $89.5M of assets against $91.3M of liabilities, leaving negative equity rather than operating-business balance-sheet strength.
In FY2025, net income of$3.0M sat beside operating cash flow of-$543K , so reported earnings were not matched by cash generated from operations. Because revenue and free cash flow are not reported, the statements provide little evidence of a recurring operating engine behind that profit.
Liabilities equal
The short-term position is particularly compressed: current assets were only
Financial Health Signals
We do not publish a peer-relative financial health score for Charlton Aria Acquisition Corporation, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
Charlton Aria Acquisition Corporation reported $138K in net income in Q3 2026. This represents a decrease of 82.9% from the same quarter a year earlier. Against the prior quarter it is down 75.7%.
Not reported for Q3 2026.
Not reported for Q3 2026.
Not reported for Q3 2026.
Cash & Balance Sheet
Charlton Aria Acquisition Corporation held $31K in cash as of Q3 2026; no long-term debt figure is on record for that period.
Not reported for Q3 2026.
Not reported for Q3 2026.
Margins & Returns
None of these metrics is reported for Q3 2026.
Capital Allocation
None of these metrics is reported for Q3 2026.
CHAR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, EBITDA, Interest Expense, Income Tax, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
CHAR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'25Filing | Q1'25Filing | Q4'24Filing |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $93.6M+5.6% | $91.9M+4.7% | $90.2M+3.7% | $89.5M+3.6% | $88.6M+42158.2% | $87.8M+60843.7% | $87.1M | $86.3M |
| Current Assets | $58K+21.5% | $56K-52.4% | $12K-95.9% | $13K-97.1% | $48K+379.8% | $119K+178.9% | $292K | $457K |
| Cash & Equivalents | $31K+187.4% | $7K-85.2% | $5K-97.5% | $5K-98.9% | $11K | $49K | $186K | $447K |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0n/m | $0n/m | $0-100.0% | $0-100.0% | $0 | $0 | $86.8M | $85.9M |
| Total Liabilities | $98.3M+8.8% | $95.0M+6.3% | $92.2M+4.2% | $91.3M+4.2% | $90.3M+27196.9% | $89.4M+66152.5% | $88.5M | $87.6M |
| Current Liabilities | $3.0M+6601.3% | $1.4M+23705.9% | $284K+442.7% | $199K+299.9% | $44K-86.6% | $6K-95.6% | $52K | $50K |
| Non-Current Liabilities | $95.3M+5.5% | $93.6M+4.7% | $91.9M+3.9% | $91.1M+4.1% | $90.3Mn/m | $89.4Mn/m | $88.5M | $87.6M |
| Total Equity | -$4.6Mn/m | -$3.1Mn/m | -$2.0Mn/m | -$1.9Mn/m | -$1.7Mn/m | -$1.6M-17454.3% | -$1.5M | -$1.3M |
| Retained Earnings | -$4.6Mn/m | -$3.1Mn/m | -$2.0Mn/m | -$1.9Mn/m | -$1.7Mn/m | -$1.6Mn/m | -$1.5M | -$1.3M |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
CHAR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
CHAR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Liabilities-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$1.9M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.07), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Charlton Aria Acquisition Corporation CHAR | FY2025 | N/A | $3.0M | N/A | $120.6M | — |
| Pantages Capital Acquisition Corporation PGAC | FY2025 | N/A | $2.5M | N/A | $119.7M | — |
| Quantumsphere Acquisition Corp. QUMS | FY2026 | N/A | $978K | N/A | $119.0M | — |
| Plum Acquisition Corp. IV PLMK | FY2025 | N/A | $6.1M | N/A | $114.0M | — |
Where Charlton Aria Acquisition Corporation Ranks
Frequently Asked Questions
Yes, Charlton Aria Acquisition Corporation (CHAR) reported a net income of $2.1M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $3.0M.
Charlton Aria Acquisition Corporation (CHAR) recorded an outflow of $543K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
Charlton Aria Acquisition Corporation (CHAR) had $89.5M in total assets as of fiscal year 2025, including both current and long-term assets.
Charlton Aria Acquisition Corporation (CHAR) had a current ratio of 0.07 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
Charlton Aria Acquisition Corporation (CHAR) had a return on assets of 3.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Charlton Aria Acquisition Corporation (CHAR) trades at 58.2x earnings, its market capitalization divided by $2.1M net income, trailing 12 months to September 30, 2026. The market capitalization is $120.6M as of Nov 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Charlton Aria Acquisition Corporation (CHAR) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $120.6M as of Nov 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Charlton Aria Acquisition Corporation (CHAR) has negative shareholder equity of -$1.9M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.